Get 20% lifetime commission for referring investors to digrin.com
here.
Olema Pharmaceuticals, Inc. (OLMA) Financials
OLMA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 486.6 million | 56.0 million |
| March 31, 2026 | 530.6 million | 50.2 million |
| Dec. 31, 2025 | 533.4 million | 54.9 million |
| Sept. 30, 2025 | 352.5 million | 45.0 million |
OLMA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -45.9 million | 12.9 million |
| March 31, 2026 | -46.0 million | 10.1 million |
| Dec. 31, 2025 | -38.3 million | 4.3 million |
| Sept. 30, 2025 | -34.5 million | 4.3 million |
OLMA Net Income
No data available :(
OLMA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 461.1 million | - | - |
| March 31, 2026 | 505.3 million | - | 956000 |
| Dec. 31, 2025 | 505.4 million | 69000 | 1.2 million |
| Sept. 30, 2025 | 329.0 million | 3.0 million | 1.5 million |
OLMA Shares Outstanding
OLMA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 57.8 million | 9.4 million | - |
| March 31, 2026 | - | 49.2 million | 8.6 million | -119000 |
| Dec. 31, 2025 | - | 43.2 million | 6.9 million | - |
| Sept. 30, 2025 | - | 40.0 million | 5.9 million | - |
OLMA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 119000 |
| Dec. 31, 2025 | - | 187000 |
| Sept. 30, 2025 | - | - |
OLMA
Price: $6.58
52 week price:
Earnings Per Share: -2.12 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 106400
Market Capitalization: 693.5 million